Skip to main content

China gives its first COVID-19 vaccine approval to Sinopharm





China approved its first COVID-19 vaccine for general public use on Thursday, a shot developed by an affiliate of state-backed pharmaceutical giant Sinopharm, as it braces for greater transmission risks over the winter.


No detailed efficacy data of the vaccine has been publicly released but its developer, Beijing Biological Products Institute, a unit of Sinopharm subsidiary China National Biotec Group (CNBG), said on Wednesday its vaccine was 79.34% effective in preventing people from developing the disease based on interim data.



The approval, announced by the National Medical Products Administration, comes after the United Arab Emirates this month became the first country to roll out the vaccine to the public, and as Pakistan announced a 1.2 million dose purchase deal with Sinopharm.

While China has been slower than several other countries in approving COVID-19 vaccines, it has been inoculating some citizens for months with three different shots still undergoing late-stage trials.

China launched an emergency use programme in July aimed at essential workers and others at high risk of infection, had administered more than 4.5 million doses as of Dec. 15 using at least three different products - two developed by CNBG and one by Sinovac Biotech.

While the efficacy of the Sinopharm shot trails the more than 90% success rate of rival vaccines from Pfizer Inc and its partner BioNTech SE and Moderna Inc, it points to progress China has made in the global race to develop successful COVID-19 vaccines.

China has at least five vaccines, developed by Sinovac, CNBG units, CanSino Biologics and the Chinese Academy of Sciences, in late stage trials, underscoring its efforts to develop a homegrown vaccine to challenge Western rivals.

President Xi Jinping has pledged to make China’s vaccines a global public good and it has won several large supply deals with countries including Indonesia and Brazil - the most populous countries in Southeast Asia and Latin America respectively.

The efficacy and safety data of China-made vaccines is being closely watched by many developing countries as they have limited early access to shots developed by Western drug makers and are looking for alternatives from China and Russia.

“China’s approval could boost the credibility of the vaccine,” said Dong-yan Jin, a professor at the University of Hong Kong.

“But if the vaccine wants to take a share in the global market, especially in developed countries, more data is necessary.”

A Sinopharm executive told a briefing detailed data would be released later and published in scientific journals at home and abroad.

While China has kept new outbreaks of the coronavirus under control, it is ramping up the emergency programme to contain the risks over the winter. The virus emerged a year ago in a market in the central city of Wuhan.

The South China Morning Post newspaper reported that China would vaccinate as many as 50 million people from high-priority groups before the Lunar New Year holiday in February.

“We call on people ... to take an active part in vaccination to protect themselves, family members and others, which is also contributing to global epidemic control,” Zeng Yixin, an official with National Health Commission, told a briefing on Thursday.

The price of the vaccine would depend on the scale of use, but the “premise” was that it would be free for the public in China, he said.

The approval comes as Britain on Wednesday approved a second COVID-19 vaccine, a shot developed by Oxford University and AstraZeneca, as it battles a major winter surge driven by a new variant of the virus.

Via Reuters 

Comments

Popular posts from this blog

EVRAA 2024: Opening Ceremony

Get ready for the sporting extravaganza of EVRAA 2024, where talented youth from across the region showcase their skills! Manila-based personalities like Andrew E., Alex Gonzaga, P-Pop Bgyo, Julie Ann San Jose, and others will grace the event alongside media and sports icons like Mike Bustos, Gretchen Ho, and Bisaya YouTube sensation Chito Samontina. Thirteen divisions will compete for the gold and the chance to represent Eastern Visayas in the PALARONG Pambansa in Cebu City. Ormoc City Siglaro Elites, last year's top division with 178 golds, is poised for another impressive performance. Ormoc City is hosting a well-prepared EVRAA, featuring a grand opening ceremony at the Ormoc City Sports Complex and the inauguration of a new Athletes Dormitory.  Stay tuned for exciting updates!"

FOKKER50: Inaugural flight from Ormoc to Cebu/Clark and vice versa

By: Wowie Phua It is with distinct honor that one of the leading travel agencies opens its line here in Ormoc. King Aces Travel & Tours Service, Inc. and Leading Edge Air Services Corp proudly introduce the Fokker50, a 50-seater plane that will fly from Cebu/Clark to Ormoc City and vice versa. People from our City and neighboring towns in West Leyte area need not go far whenever they feel the need to explore the unscatched beauty of the metropolis, they can now fly comfortably from Ormoc to Cebu or Clark in their convenient schedule every Friday. Fare rates (for October only) are P1,600.00 p/pax one way for flights from Cebu to Ormoc and P2,950.00 p/pax one way for flights from Clark to Ormoc. Rates may vary anytime. They're also considering giving promo rates for the holiday season. FLIGHT SCHEDULE 0930H - 1030H Gen. Aviation Mactan Cebu to Ormoc Airport 1100H - 1200H Ormoc Airport to Gen. Aviation Mactan Cebu 0800H - 1000H Clark International ...

Ejercito: Passage of bill granting civil service eligibility to SK kagawads

Senator Joseph Victor “JV” Ejercito on Thursday urged lawmakers to pass the measure that seeks to grant civil service eligibility to Sangguniang Kabataan (SK) councilors. Ejercito, in filing Senate Bill No. 2185, or the bill that seeks to amend the Sangguniang Kabataan (SK) Reform Act of 2015 (Republic Act No. 10742), said he believed youth councilors should also be granted civil service eligibility. The senator noted that under the present law, SK councilors are not included in the list of Elective Barangay Officials to be provided or granted with first level eligibility under the Civil Service Rules. He said that based on the Civil Service Rules, a Barangay Official Eligibility, which is equivalent to Career Service Sub-professional Eligibility, is a privilege granted to barangay officials, including SK chairpersons. He said the bill “seeks to grant the same, if not more fitting privilege to SK kagawads, recognizing them also as barangay elected officials.” “Through the SK Ref...